Recycling of epidermal growth factor in a human pancreatic carcinoma cell line
- PMID: 2994064
- PMCID: PMC391014
- DOI: 10.1073/pnas.82.18.6172
Recycling of epidermal growth factor in a human pancreatic carcinoma cell line
Abstract
PANC-1 human pancreatic carcinoma cells readily bound and internalized 125I-labeled epidermal growth factor (EGF). Bound 125I-labeled EGF was then partially processed to a number of high molecular weight acidic species. Percoll gradient centrifugation of cell homogenates indicated that the majority of 125I activity localized to several intracellular vesicular compartments. Both intact EGF and its processed species were subsequently released into the incubation medium. A major portion of the released radioactivity was capable of rebinding to the cell. Only a small amount of bound 125I-labeled EGF was degraded to low molecular weight products, and this degradation was completely blocked by methylamine. This lysosomotropic compound did not arrest either the generation or the extrusion of the major high molecular weight species of processed EGF (pI 4.2). These findings suggest that in PANC-1 cells, bound EGF undergoes only limited processing. Both intact EGF and its major processed species bypass the cellular degradative pathways, are slowly released from the cell, and then rebind to the cell.
Similar articles
-
Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-alpha.J Biol Chem. 1989 Sep 5;264(25):14990-9. J Biol Chem. 1989. PMID: 2788651
-
Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells.Life Sci. 1985 May 13;36(19):1849-55. doi: 10.1016/0024-3205(85)90158-4. Life Sci. 1985. PMID: 2985903
-
Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells.J Cell Biol. 1986 Mar;102(3):878-88. doi: 10.1083/jcb.102.3.878. J Cell Biol. 1986. PMID: 2869047 Free PMC article.
-
Characterization of the rebinding of 125I-epidermal growth factor released from BALB/c-3T3 cells following accumulation in the presence of chloroquine.J Cell Physiol. 1988 Mar;134(3):387-95. doi: 10.1002/jcp.1041340309. J Cell Physiol. 1988. PMID: 3258311
-
Biosynthesis and metabolic degradation of receptors for epidermal growth factor.J Membr Biol. 1986;90(2):97-105. doi: 10.1007/BF01869927. J Membr Biol. 1986. PMID: 3014153 Review. No abstract available.
Cited by
-
Augmentation of chemically induced pancreatic and bronchial cancers by epidermal growth factor.Gut. 1987;28 Suppl(Suppl):249-51. doi: 10.1136/gut.28.suppl.249. Gut. 1987. PMID: 3319811 Free PMC article.
-
Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors.J Mol Med (Berl). 1996 Jan;74(1):35-42. doi: 10.1007/BF00202070. J Mol Med (Berl). 1996. PMID: 8834768 Review.
-
Potential role of the epidermal growth factor receptor in human pancreatic cancer.Int J Pancreatol. 1990 Aug-Nov;7(1-3):71-81. doi: 10.1007/BF02924222. Int J Pancreatol. 1990. PMID: 2081930 Review.
-
cDNA cloning of the developmentally regulated lamin LIII of Xenopus laevis.EMBO J. 1988 Oct;7(10):3189-97. doi: 10.1002/j.1460-2075.1988.tb03186.x. EMBO J. 1988. PMID: 3181134 Free PMC article.
-
Transforming growth factor alpha (TGF-alpha) increases cell number in a human pancreatic cancer cell line but not in normal mouse pancreas.Int J Pancreatol. 2000 Dec;28(3):199-205. doi: 10.1385/IJGC:28:3:199. Int J Pancreatol. 2000. PMID: 11373057
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous